Search hospitals > California > Stanford
Stanford Health Care
Claim this profileStanford, California 94305
Conducts research for High Blood Pressure
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Pulmonary Arterial Hypertension
Conducts research for Pulmonary Hypertension
63 reported clinical trials
8 medical researchers
Summary
Stanford Health Care is a medical facility located in Stanford, California. This center is recognized for care of High Blood Pressure, Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia-Lymphoma, Pulmonary Arterial Hypertension, Pulmonary Hypertension and other specialties. Stanford Health Care is involved with conducting 63 clinical trials across 136 conditions. There are 8 research doctors associated with this hospital, such as Robert Lowsky, MD, Everett Meyer, MD, Sally Arai, MD, and Ban Tsui, MD.Area of expertise
1High Blood Pressure
2Acute Lymphoblastic Leukemia
HLA-A positive
HLA-A negative
HLA positive
Top PIs
Robert Lowsky, MDStanford University1 year of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
13 reported clinical trials
21 drugs studied
Everett Meyer, MDStanford University1 year of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
11 reported clinical trials
23 drugs studied
Sally Arai, MDStanford University3 years of reported clinical research
Studies Lymphoblastic Leukemia-Lymphoma
Studies Acute Lymphoblastic Leukemia
8 reported clinical trials
23 drugs studied
Ban Tsui, MDLucille Packard Children's Hospital2 years of reported clinical research
Studies Rib Fractures
Studies Broken Bones
6 reported clinical trials
10 drugs studied
Clinical Trials running at Stanford Health Care
Pulmonary Arterial Hypertension
Follicular Lymphoma
Cancer
Fibrosis
Pulmonary Hypertension
High Blood Pressure
Leukemia
Atrial Fibrillation
Lymphoma
Tumors
Seralutinib
for Pulmonary Arterial Hypertension
This trial is testing a medication called seralutinib to see if it can help people with a specific type of lung disease (PAH) improve their ability to exercise. The medication works by blocking signals that cause the blood vessels in the lungs to tighten and narrow. Seralutinib is delivered via inhalation and is being developed for patients with pulmonary arterial hypertension. The goal is to see if this can reduce lung pressure and delay worsening of the disease.
Recruiting1 award Phase 313 criteria
GB002
for Pulmonary Arterial Hypertension
This trial will study the long-term effects of GB002 (seralutinib) in patients who were part of an earlier study for Pulmonary Arterial Hypertension (PAH). Seralutinib is a new treatment developed for PAH and has shown better results compared to another treatment in early studies.
Recruiting1 award Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stanford Health Care?
Stanford Health Care is a medical facility located in Stanford, California. This center is recognized for care of High Blood Pressure, Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia-Lymphoma, Pulmonary Arterial Hypertension, Pulmonary Hypertension and other specialties. Stanford Health Care is involved with conducting 63 clinical trials across 136 conditions. There are 8 research doctors associated with this hospital, such as Robert Lowsky, MD, Everett Meyer, MD, Sally Arai, MD, and Ban Tsui, MD.